Episode

GLP-1 Drugs Could Help Veterans with Alcohol Use | Minneapolis News

Podcast
Minneapolis News Today | 2 Min News | The Daily News Now!
Published
Aug 1, 2026
Duration seconds
98
Processing state
not_requested
Canonical source
https://sources.thednn.ai/1f1e04df3d62a93b
Audio
https://api.fastcast.ai/audio/c1a2c42a-d0f4-49a3-834d-659269897736.mp3
JSON
/v1/public/podcasts/minneapolis-news-today-2-min-news-the-daily-news-now-7564425/episodes/glp-1-drugs-could-help-veterans-with-alcohol-use-minneapolis-news
Markdown
/podcast/minneapolis-news-today-2-min-news-the-daily-news-now-7564425/glp-1-drugs-could-help-veterans-with-alcohol-use-minneapolis-news.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/minneapolis-news-today-2-min-news-the-daily-news-now-7564425/episodes/glp-1-drugs-could-help-veterans-with-alcohol-use-minneapolis-news/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/minneapolis-news-today-2-min-news-the-daily-news-now-7564425/glp-1-drugs-could-help-veterans-with-alcohol-use-minneapolis-news.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Veterans battling alcohol use disorder may soon have a new weapon: GLP-1 drugs like semaglutide, originally used for weight loss. In a groundbreaking clinical trial across 18 VA sites—including Minneapolis—researchers are testing whether these medications can help thousands of veterans struggling with addiction. Led by Dr. Eric Dieperink, the 24-week study randomly assigns participants to either the drug or placebo, aiming to add a powerful new tool to existing treatments. With limited options and rising need, this research could unlock transformative hope for a community in crisis. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/1f1e04df3d62a93b